BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements

  June 17, 2025

   · 

  6 min read
• Press Releases

  Lung Cancer Research Foundation Announces New Research Collaboration with Boehringer Ingelheim

  June 17, 2025

   · 

  6 min read
• Press Releases

  Skyhawk Therapeutics Announces First Patient Dosed in Phase 2/3 FALCON-HD Trial of SKY-0515 for Huntington’s Disease

  June 17, 2025

   · 

  4 min read
• Press Releases

  NMDP’s ACCESS Trial Results Published in Journal of Clinical Oncology, Demonstrating Strong Outcomes with Mismatched Unrelated Donors in Adult Stem Cell Transplantation

  June 17, 2025

   · 

  4 min read
• Press Releases

  Nikon Instruments and Astellas announce a strategic collaboration to offer SakuLab-Cambridge MA resident companies access to advanced imaging capabilities provided by Nikon BioImaging Lab USA

  June 17, 2025

   · 

  2 min read
• Press Releases

  Zetagen Therapeutics Announces Peer-reviewed Publication of In-Vivo Dose Optimization Findings for ZetaMast™ (Zeta-MBC-005) for Triple Negative Breast Cancer Liver Metastases

  June 17, 2025

   · 

  4 min read
• Press Releases

  ChoiceSpine™ Announces Launch of ChoiceSpine™ App for Surgical Use with eCential Robotics Op.n™ Robotic and Navigation Platform

  June 17, 2025

   · 

  3 min read
• Press Releases

  Singlera Genomics and Partners publish results from GUIDE prospective cohort study demonstrating blood-based early detection of gastrointestinal cancers using DNA methylation-based GutSeer assay

  June 17, 2025

   · 

  4 min read
• Press Releases

  Spyre Therapeutics to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trials for its SPY002 Program, its Novel Half-Life Extended Anti-TL1A Antibodies on June 17, 2025

  June 17, 2025

   · 

  1 min read
• Press Releases

  Quiver Bioscience Appoints Graham Dempsey, PhD as Chief Executive Officer to Lead Scaling of AI-Driven CNS Platform and Advance Lead Program into the Clinic

  June 17, 2025

   · 

  3 min read